Skip to main content
Top
Published in: Obesity Surgery 9/2019

01-09-2019 | Bariatric Surgery | Original Contributions

Bone Turnover Markers After Standard and Distal Roux-en-Y Gastric Bypass: Results from a Randomized Controlled Trial

Authors: Marius Svanevik, Hilde Risstad, Dag Hofsø, Ingvild K Blom-Høgestøl, Jon A. Kristinsson, Rune Sandbu, Milada Cvancarova Småstuen, Per Medbøe Thorsby, Tom Mala, Jøran Hjelmesæth

Published in: Obesity Surgery | Issue 9/2019

Login to get access

Abstract

Background

Roux-en-Y gastric bypass is associated with increased risk of bone fractures. Malabsorptive procedures may be associated with secondary hyperparathyroidism and detrimental effects on bone health. We aimed to compare the effects of standard and distal gastric bypass on bone turnover markers 2 years after surgery.

Methods

Patients with body mass index (BMI) 50–60 kg/m2 (n = 113) were randomized to standard or distal gastric bypass, 105 patients (95%) completed 2-year follow-up. Serum C-terminal telopeptide of type I collagen (CTX-1), procollagen type I N-propeptide (PINP), and bone-derived alkaline phosphatase (BALP) was measured at baseline and up to 2 years after surgery. ANCOVA and linear mixed models were used to compare groups.

Results

The levels of bone turnover markers increased significantly in both groups, with no statistically significant difference between groups. Two years after standard and distal gastric bypass mean (SD) CTX-1 were 0.81 (0.32) and 0.83 (0.31) μg/L (p = 0.38), mean PINP was 77.6 (23.2) and 77.7 (29.3) μg/L (p = 0.42), and BALP 47.9 (21.9) vs. 50.7 (19.6) μg/L (p = 0.38), respectively. Multiple linear regression analyses showed that PINP and BALP correlated positively (p = 0.01 and p < 0.001) with PTH, but only BALP was significantly higher in patients with secondary hyperparathyroidism (p = 0.001). Type of surgery, vitamin D serum concentrations, and 2-year BMI were all independently associated with PTH levels.

Conclusion

A comparable increase in bone turnover markers 2 years after standard and distal gastric bypass was observed. There was a higher prevalence of secondary hyperparathyroidism after distal gastric bypass, but this did not impact bone turnover markers.

Trial Registration

Clinical Trials.​gov number NCT00821197.
Appendix
Available only for authorised users
Literature
1.
go back to reference Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25:1822–32.CrossRefPubMed
2.
go back to reference Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016:3794–12. Rousseau C, Jean S, Gamache P, et al. Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study. BMJ. 2016:3794–12.
4.
5.
go back to reference Hofsø D, Bollerslev J, Sandbu R, et al. Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists. Endocrine. Springer US. 2016;53:313–21.CrossRefPubMed Hofsø D, Bollerslev J, Sandbu R, et al. Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists. Endocrine. Springer US. 2016;53:313–21.CrossRefPubMed
6.
go back to reference Raoof M, Näslund I, Rask E, et al. Effect of gastric bypass on bone mineral density, parathyroid hormone and vitamin D: 5 years follow-up. Obes Surg. Springer US. 2016;26:1141–5.CrossRefPubMed Raoof M, Näslund I, Rask E, et al. Effect of gastric bypass on bone mineral density, parathyroid hormone and vitamin D: 5 years follow-up. Obes Surg. Springer US. 2016;26:1141–5.CrossRefPubMed
7.
go back to reference Switzer NJ, Marcil G, Prasad S, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017;18:560–6.CrossRefPubMed Switzer NJ, Marcil G, Prasad S, et al. Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review. Obes Rev. 2017;18:560–6.CrossRefPubMed
8.
go back to reference Schafer AL, Weaver CM, Black DM, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30:1377–85.CrossRefPubMed Schafer AL, Weaver CM, Black DM, et al. Intestinal calcium absorption decreases dramatically after gastric bypass surgery despite optimization of vitamin D status. J Bone Miner Res. 2015;30:1377–85.CrossRefPubMed
9.
go back to reference Brzozowska MM, Sainsbury A, Eisman JA, et al. Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev. 2012;14:52–67.CrossRefPubMed Brzozowska MM, Sainsbury A, Eisman JA, et al. Bariatric surgery, bone loss, obesity and possible mechanisms. Obes Rev. 2012;14:52–67.CrossRefPubMed
10.
go back to reference Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10:259–64.CrossRefPubMed Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int. 1999;10:259–64.CrossRefPubMed
11.
go back to reference Siris ES, Chen Y-T, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med American Medical Association. 2004;164:1108–12.CrossRefPubMed Siris ES, Chen Y-T, Abbott TA, et al. Bone mineral density thresholds for pharmacological intervention to prevent fractures. Arch Intern Med American Medical Association. 2004;164:1108–12.CrossRefPubMed
12.
go back to reference Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14 Suppl(5):118–27.CrossRef Bouxsein ML. Bone quality: where do we go from here? Osteoporos Int. 2003;14 Suppl(5):118–27.CrossRef
13.
go back to reference Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res Wiley-Blackwell. 1996;11:1531–8.CrossRefPubMed Garnero P, Hausherr E, Chapuy MC, et al. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS prospective study. J Bone Miner Res Wiley-Blackwell. 1996;11:1531–8.CrossRefPubMed
14.
15.
go back to reference Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg. 2002;12:540–5.CrossRefPubMed Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg. 2002;12:540–5.CrossRefPubMed
16.
go back to reference Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg. 2005;15:51–7.CrossRefPubMed Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg. 2005;15:51–7.CrossRefPubMed
17.
go back to reference Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008;4:521–5.CrossRefPubMed Pinheiro JS, Schiavon CA, Pereira PB, et al. Long-long limb Roux-en-Y gastric bypass is more efficacious in treatment of type 2 diabetes and lipid disorders in super-obese patients. Surg Obes Relat Dis. 2008;4:521–5.CrossRefPubMed
18.
go back to reference Risstad H, Svanevik M, Kristinsson JA, et al. Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60. JAMA Surg. 2016;151:1146–10.CrossRefPubMed Risstad H, Svanevik M, Kristinsson JA, et al. Standard vs distal Roux-en-Y gastric bypass in patients with body mass index 50 to 60. JAMA Surg. 2016;151:1146–10.CrossRefPubMed
19.
go back to reference Svanevik M, Risstad H, Hofsø D, et al. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50−60 kg/m(2)--a double-blind, Randomized Controlled Trial. Obes Surg. 2015;25:1788–95.CrossRefPubMedPubMedCentral Svanevik M, Risstad H, Hofsø D, et al. Perioperative outcomes of proximal and distal gastric bypass in patients with BMI ranged 50−60 kg/m(2)--a double-blind, Randomized Controlled Trial. Obes Surg. 2015;25:1788–95.CrossRefPubMedPubMedCentral
20.
go back to reference Cashman KD, Dowling KG, Škrabáková Z, et al. Standardizing serum 25-hydroxyvitamin D data from four Nordic population samples using the vitamin D standardization Programprotocols: shedding new light on vitamin D status in Nordic individuals. Scand J Clin Lab Invest. 2015;75:549–61.CrossRefPubMed Cashman KD, Dowling KG, Škrabáková Z, et al. Standardizing serum 25-hydroxyvitamin D data from four Nordic population samples using the vitamin D standardization Programprotocols: shedding new light on vitamin D status in Nordic individuals. Scand J Clin Lab Invest. 2015;75:549–61.CrossRefPubMed
21.
go back to reference Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the sSurgical Weight Loss Patient 2016 Update_ Micronutrients. SOARD. Elsevier Inc. 2017;13:727–41. Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the sSurgical Weight Loss Patient 2016 Update_ Micronutrients. SOARD. Elsevier Inc. 2017;13:727–41.
22.
go back to reference Muschitz C, Kocijan R, Haschka J, et al. The impact of vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study. J Bone Miner Res. 2015;31:672–82.CrossRefPubMed Muschitz C, Kocijan R, Haschka J, et al. The impact of vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study. J Bone Miner Res. 2015;31:672–82.CrossRefPubMed
23.
go back to reference Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline. JAMA Intern Med. 2016;176:175–9.CrossRefPubMed Bischoff-Ferrari HA, Dawson-Hughes B, Orav EJ, et al. Monthly high-dose vitamin D treatment for the prevention of functional decline. JAMA Intern Med. 2016;176:175–9.CrossRefPubMed
24.
go back to reference Hewitt S, Søvik TT, Aasheim ET, et al. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg. Springer-Verlag. 2012;23:384–90.CrossRef Hewitt S, Søvik TT, Aasheim ET, et al. Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch. Obes Surg. Springer-Verlag. 2012;23:384–90.CrossRef
25.
go back to reference Bredella MA, Greenblatt LB, Eajazi A, et al. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue. Bone. 2017;95:85–90.CrossRefPubMed Bredella MA, Greenblatt LB, Eajazi A, et al. Effects of Roux-en-Y gastric bypass and sleeve gastrectomy on bone mineral density and marrow adipose tissue. Bone. 2017;95:85–90.CrossRefPubMed
26.
go back to reference Ivaska KK, Huovinen V, Soinio M, et al. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone Elsevier Inc. 2017;95:47–54.CrossRefPubMed Ivaska KK, Huovinen V, Soinio M, et al. Changes in bone metabolism after bariatric surgery by gastric bypass or sleeve gastrectomy. Bone Elsevier Inc. 2017;95:47–54.CrossRefPubMed
27.
go back to reference Bowen J, Noakes M, Clifton PM. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J Nutr. 2004;134:568–73.CrossRefPubMed Bowen J, Noakes M, Clifton PM. A high dairy protein, high-calcium diet minimizes bone turnover in overweight adults during weight loss. J Nutr. 2004;134:568–73.CrossRefPubMed
28.
go back to reference Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250–61.CrossRefPubMed Seeman E, Delmas PD. Bone quality--the material and structural basis of bone strength and fragility. N Engl J Med. 2006;354:2250–61.CrossRefPubMed
29.
go back to reference Crawford MR, Pham N, Khan L, et al. Increased bone turnover in type 2 diabetes patients randomized to bariatric surgery versus medical therapy at 5 years. Endocr Pract. American Association of Clinical Endocrinologists Corporation, INC. 2018;24:256–64.CrossRefPubMed Crawford MR, Pham N, Khan L, et al. Increased bone turnover in type 2 diabetes patients randomized to bariatric surgery versus medical therapy at 5 years. Endocr Pract. American Association of Clinical Endocrinologists Corporation, INC. 2018;24:256–64.CrossRefPubMed
30.
go back to reference Wei JH, Lee WJ, Chong K, et al. High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures. Obes Surg. 2018;28(3):798–804.CrossRef Wei JH, Lee WJ, Chong K, et al. High Incidence of Secondary Hyperparathyroidism in Bariatric Patients: Comparing Different Procedures. Obes Surg. 2018;28(3):798–804.CrossRef
31.
go back to reference Nergaard BJ, Leifsson BG, Hedenbro J, et al. Gastric bypass with long alimentary limb or long pancreato-biliary limb—long-term results on weight loss, resolution of co-morbidities and metabolic parameters. Obes Surg Springer US, 2014;24:1595–602.CrossRefPubMedPubMedCentral Nergaard BJ, Leifsson BG, Hedenbro J, et al. Gastric bypass with long alimentary limb or long pancreato-biliary limb—long-term results on weight loss, resolution of co-morbidities and metabolic parameters. Obes Surg Springer US, 2014;24:1595–602.CrossRefPubMedPubMedCentral
32.
go back to reference Røislien J, Van Calster B, Hjelmesaeth J Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol. BioMed Central Ltd; 2011;10:17.CrossRefPubMedPubMedCentral Røislien J, Van Calster B, Hjelmesaeth J Parathyroid hormone is a plausible mediator for the metabolic syndrome in the morbidly obese: a cross-sectional study. Cardiovasc Diabetol. BioMed Central Ltd; 2011;10:17.CrossRefPubMedPubMedCentral
Metadata
Title
Bone Turnover Markers After Standard and Distal Roux-en-Y Gastric Bypass: Results from a Randomized Controlled Trial
Authors
Marius Svanevik
Hilde Risstad
Dag Hofsø
Ingvild K Blom-Høgestøl
Jon A. Kristinsson
Rune Sandbu
Milada Cvancarova Småstuen
Per Medbøe Thorsby
Tom Mala
Jøran Hjelmesæth
Publication date
01-09-2019
Publisher
Springer US
Published in
Obesity Surgery / Issue 9/2019
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-019-03909-1

Other articles of this Issue 9/2019

Obesity Surgery 9/2019 Go to the issue